PlainRecalls
FDA Drug Low Class III Terminated

Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4

Reported: January 4, 2023 Initiated: December 21, 2022 #D-0093-2023

Product Description

Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4

Reason for Recall

Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Details

Recalling Firm
Apotex Corp.
Units Affected
22,027 bottles
Distribution
USA Nationwide
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4. Recalled by Apotex Corp.. Units affected: 22,027 bottles.
Why was this product recalled?
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 4, 2023. Severity: Low. Recall number: D-0093-2023.